Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac
Mandate

Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac

April 11, 2022 Banking and Finance Commercial Agreements Intellectual Property M&A Corporate Crime & Compliance IT, Telecommunications and Outsourcing Real Estate and Construction Environmental Law

Eson Pac are packaging specialists providing solutions for the pharma packaging supply chain. Mayr-Melnhof Group (“MM”) has acquired 100% of the shares in Eson Pac from the majority shareholder Nalka Invest AB as well as the founding family and management minority shareholders. MM is Europe’s leading producer of cartonboard and folding cartons as well as kraft papers and uncoated fine papers.

Vinge’s team consisted of Matthias Pannier, Ulrich Ziche, Måns Håkanson and Elias Bohlin (M&A), Felix Möller and Ellen Flygt (Banking and Finance), Elin Broman and Emil Lindwall (Employment), Michael Montner (IP), Mario Saad (Commercial Agreements), Mika Jordan (IT), Tove Tullberg (Compliance), Frida Ställborn (Real Property), Johan Cederblad and Lina Österberg (Environmental law).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025